Home » TIGRIS PHARMACEUTICALS RAISES $11.6 MILLION IN PRIVATE PLACEMENT
TIGRIS PHARMACEUTICALS RAISES $11.6 MILLION IN PRIVATE PLACEMENT
Tigris Pharmaceuticals, Inc., a privately held drug development company, recently completed a private placement of Series A Convertible Preferred Stock with institutional and other accredited investors resulting in gross proceeds of approximately $11.6 million, which includes the conversion of approximately $1.6 million of previously issued convertible debt.
Yahoo News (http://biz.yahoo.com/prnews/051017/nym240.html?.v=8)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May